Results 41 to 50 of about 35,220 (306)
Continuous glucose monitoring sensors: Past, present and future algorithmic challenges [PDF]
, 2016 Continuous glucose monitoring (CGM) sensors are portable devices that allow measuring and visualizing the glucose concentration in real time almost continuously for several days and are provided with hypo/hyperglycemic alerts and glucose trend ...
Facchinetti, Andrea
core +2 more sources
Advanced Functional Materials, EarlyView.An oral nanoplatform, MOP@T@D, which can maintain glucose homeostasis and restore islet β cells in diabetic rats is developed. It achieves efficient intestinal absorption and liver‐targeted delivery. The nanoparticle disintegrates only in response to hyperglycemia to release insulin on demand and provides antioxidant protection through selenoprotein ...
Chenxiao Chu +14 more
wiley +1 more source
Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2019 Aims: The purpose of this study was to assess the impact of continuous subcutaneous insulin infusion therapy (CSII) on glycosylated haemoglobin level (HbA1c), total daily dose of insulin (TDD), weight, episodes of diabetic ketoacidosis (DKA), severe ...
Suji Prabhaharan +2 more
doaj +1 more source
Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. [PDF]
, 2017 Disruption of hepatocyte growth hormone (GH) signaling through disruption of Jak2 (JAK2L) leads to fatty liver. Previously, we demonstrated that development of fatty liver depends on adipocyte GH signaling.
Camporez, João Paulo G +10 more
core +1 more source
Strategies for Loading and Releasing Peptide Therapeutics in Biodegradable Carriers
Advanced Functional Materials, EarlyView.A biodegradable carrier‐based peptide delivery system is a powerful treatment platform for diverse diseases, owing to its superior therapeutic efficacy and low toxicity. This review examines the conventional peptide‐loaded carrier fabrication process and its current limitations.
Wookyoung Jang, Ki Wan Bong
wiley +1 more source
Diabetic ketoacidosis: Should current management include subcutaneous insulin injections?
Southwest Respiratory and Critical Care Chronicles, 2017 Diabetic ketoacidosis is a well-known acute complication in patients with both type 1 and type 2 diabetes mellitus. Although mortality has decreased considerably, it remains an important cause for admission to intensive care units.
Rocio Gavidia Quezada, Hawa Edriss
doaj +1 more source
A Continuous Subcutaneous Insulin Infusion Needle Break [PDF]
Clinical Diabetes, 2015 ### Adverse Event Our patient was 13 years and 2 months old, a white boy with type 1 diabetes diagnosed 2 years and 5 months before this adverse event (AE). He had no other significant medical history. His A1C was 7.6% 1 month before the insulin infusion needle break event.
George, Minu M. +2 more
openaire +2 more sources
Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report [PDF]
, 2009 A 14 year old female with type 1 diabetes mellitus and a subcutaneous insulin pump was treated for diabetic ketoacidosis presumed secondary to dietary indiscretion, and then restarted her subcutaneous insulin pump after exchanging the tubing.
Baird, John Scott
core +2 more sources
Advanced Healthcare Materials, EarlyView.Models of the human skin must combine the relevant biological contents and suitable biomaterials with the correct spatial organization. Performing compound screening on such in vitro models also requires fast and reproducible production methods of the models.
Elisa Lenzi +7 more
wiley +1 more source
A Pilot Study of a Comparison of Glycemic Control in Critically Ill Patients
Journal of Health Science and Medical Research (JHSMR), 2010 Objective: To compare glycemic control in the critically ill patients between a single dose of subcutaneous injection of insulin glargine and a continuous intravenous infusion of regular insulin.
Rungsun Bhurayanontachai +2 more
doaj